Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients
- PMID: 11022833
- DOI: 10.1046/j.1440-1746.2000.02229.x
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients
Abstract
Background: The aim of the present paper was to determine the efficacy and tolerability of a 1-week treatment regimen consisting of pantoprazole and two antibiotics: clarithromycin and amoxycillin, in the eradication of Helicobacter pylori.
Methods: The patients selected had unequivocal evidence of H. pylori infection based on urease test, culture and histology on antral and corpus biopsies obtained at endoscopy. Patients received pantoprazole 40 mg twice a day, clarithromycin 500 mg twice a day and amoxycillin 1 g twice a day for 1 week and were assessed for successful eradication at least 4 weeks after completion of therapy by repeat gastroscopy and gastric biopsies. Eradication was defined as absence of bacteria in both antral and corpus biopsies tested by culture, histology and urease test.
Results: One hundred and six patients were recruited for the study. The mean age was 48.0 years (range: 23-74 years). Four patients defaulted follow up and five patients were not compliant (taking less than 85%) with medications. Eradication rates on per-protocol analysis were: 88/97 (90.7%; 95% CI: 83.1-95.7); and on intention-to-treat analysis they were: 88/106 (83.0%; 95% CI: 75.9-90.2). Side-effects were in general mild and tolerable: 57 of 106 (53.7%) patients complained of a bitter taste; 15 (14.1%) complained of giddiness; 10 (9.4%) complained of increased abdominal pain; 11 (11.5%) complained of lethargy and 16 (15.1%) complained of loose motions. Pre-treatment metronidazole resistance was encountered in 57/74 strains (77.0%). Clarithromycin resistance was not encountered in any of the strains.
Conclusions: The pantoprazole 1-week triple therapy with amoxycillin and clarithromycin is effective in H. pylori eradication. The treatment was well tolerated by patients. Metronidazole resistance was reported in a high percentage of strains isolated from patients. Clarithromycin resistance was, however, not detected in any of the strains.
Similar articles
-
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.Aliment Pharmacol Ther. 1998 Jun;12(6):545-50. doi: 10.1046/j.1365-2036.1998.00343.x. Aliment Pharmacol Ther. 1998. PMID: 9678814 Clinical Trial.
-
Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.Hepatogastroenterology. 1999 Jan-Feb;46(25):245-51. Hepatogastroenterology. 1999. PMID: 10228801 Clinical Trial.
-
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.Aliment Pharmacol Ther. 1999 Nov;13(11):1523-30. doi: 10.1046/j.1365-2036.1999.00646.x. Aliment Pharmacol Ther. 1999. PMID: 10571611 Clinical Trial.
-
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].Rev Clin Esp. 1998 Oct;198(10):678-83. Rev Clin Esp. 1998. PMID: 9844458 Review. Spanish. No abstract available.
-
Triple therapy as a cure for Helicobacter pylori infection.Eur J Gastroenterol Hepatol. 1996 Oct;8 Suppl 1:S27-30. doi: 10.1097/00042737-199610001-00006. Eur J Gastroenterol Hepatol. 1996. PMID: 8930577 Review.
Cited by
-
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Molecules. 2015 Apr 8;20(4):6068-92. doi: 10.3390/molecules20046068. Molecules. 2015. PMID: 25856059 Free PMC article. Review.
-
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006. Drugs. 2003. PMID: 12487624 Review.
-
Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia-findings from a molecular based study.PeerJ. 2021 Jun 9;9:e11518. doi: 10.7717/peerj.11518. eCollection 2021. PeerJ. 2021. PMID: 34178444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical